Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedLicence not statedClinical Pharmacology and Therapeutics

Use of SGLT2 Inhibitors, GLP‐1 Receptor Agonists, and DPP‐4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations

  • Ying‐Hsuan Lin1
  • Daniel Hsiang‐Te Tsai2,3
  • Miyuki Hsing‐Chun Hsieh2,3
  • Chia‐Chun Lee1
  • Chin‐Chung Tseng1
  • Ming‐Cheng Wang1
  • Edward Chia‐Cheng Lai2,3
  • Kuan‐Hung Liu1,4
4 affiliations
  1. 1Division of Nephrology, Department of Internal Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan City Taiwan
  2. 2School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University Tainan Taiwan
  3. 3Population Health Data Center, National Cheng Kung University Tainan Taiwan
  4. 4Institute of Clinical Medicine, College of Medicine, National Cheng Kung University Tainan Taiwan
Read full textDOICite

Related

  1. Sodium-glucose cotransporter 2 inhibitors vs. glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for incident and recurrent urolithiasis: a European Association of Urology Endourology systematic review
    Arianna Pischetola, Francesco Esperto, Arman Tsaturyan +4
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
    Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
  3. Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation
    Rohit Vashisht, Sanket S. Dhruva, Ayan Patel +8
    Journal of Diabetes Science and TechnologyPeer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
  4. Perioperative management of GLP-1 receptor agonists and SGLT2 inhibitors: An updated review for anesthesiologists.
    Amer Majeed, Rida R Amir, Sajjad Rasool Dar +1
    Saudi journal of anaesthesiaPeer-reviewedCC BY-NC-SAFull textEndocrinology & metabolismEurope PMCPMC
  5. Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon‐Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta‐Analysis
    Frances Perry, Silvia J. Leon, Kate Polecina +10
    Diabetes, Obesity & MetabolismPeer-reviewedCC BY-NC 4.0Full textEndocrinology & metabolismPMC

Cite

BibTeXRIS
BibTeX
@article{lin2026sglt2,
  title = {{Use of SGLT2 Inhibitors, GLP‐1 Receptor Agonists, and DPP‐4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations}},
  author = {Ying‐Hsuan Lin and Daniel Hsiang‐Te Tsai and Miyuki Hsing‐Chun Hsieh and Chia‐Chun Lee and Chin‐Chung Tseng and Ming‐Cheng Wang and Edward Chia‐Cheng Lai and Kuan‐Hung Liu},
  journal = {Clinical Pharmacology and Therapeutics},
  year = {2026},
  month = oct,
  doi = {10.1002/cpt.70536},
  url = {https://doi.org/10.1002/cpt.70536},
}
RIS
TY  - JOUR
TI  - Use of SGLT2 Inhibitors, GLP‐1 Receptor Agonists, and DPP‐4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations
AU  - Ying‐Hsuan Lin
AU  - Daniel Hsiang‐Te Tsai
AU  - Miyuki Hsing‐Chun Hsieh
AU  - Chia‐Chun Lee
AU  - Chin‐Chung Tseng
AU  - Ming‐Cheng Wang
AU  - Edward Chia‐Cheng Lai
AU  - Kuan‐Hung Liu
PY  - 2026
DA  - 2026/10/26
JO  - Clinical Pharmacology and Therapeutics
DO  - 10.1002/cpt.70536
UR  - https://doi.org/10.1002/cpt.70536
SN  - 0009-9236
SN  - 1532-6535
ER  -